Curaleaf (OTCMKTS:CURLF) Shares Gap Down on Analyst Downgrade

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) shares gapped down before the market opened on Friday after Atb Cap Markets downgraded the stock from a strong-buy rating to a hold rating. The stock had previously closed at $2.85, but opened at $2.47. Curaleaf shares last traded at $2.3450, with a volume of 71,306 shares traded.

Several other equities analysts have also commented on CURLF. Canaccord Genuity Group raised Curaleaf to a “strong-buy” rating in a report on Thursday, October 9th. Cormark raised Curaleaf from a “hold” rating to a “moderate buy” rating in a research report on Friday, August 8th. Two equities research analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Buy”.

Curaleaf Trading Down 2.9%

The business’s 50-day moving average price is $2.86 and its 200-day moving average price is $1.83. The firm has a market capitalization of $1.59 billion, a PE ratio of -7.38 and a beta of 0.71. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.47 and a quick ratio of 0.70.

Curaleaf (OTCMKTS:CURLF) last issued its quarterly earnings results on Wednesday, November 5th. The company reported ($0.06) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.01. Curaleaf had a negative net margin of 19.50% and a negative return on equity of 15.54%. As a group, analysts expect that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current fiscal year.

About Curaleaf

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.